Alzheimer’s Blood Test for Early Detection

Ariana Wilson and Mark Drlik seated against a white background, wearing lavalier microphones. The woman on the left has long brown curly hair and is wearing a beige cardigan over a taupe top. The man on the right is wearing glasses and a blue button-up shirt. They appear to be engaged in conversation or a video interview.
Resources

Alzheimer’s Blood Test for Early Detection

Sector: Diagnostics

In this episode of MedDevice by Design, we explore a groundbreaking shift in how Alzheimer’s disease may soon be diagnosed. Instead of relying on invasive spinal taps or costly PET scans, researchers have developed a blood test that detects key proteins associated with the disease—offering a more accessible and patient-friendly screening method.

A Simpler Diagnostic Pathway

Traditionally, Alzheimer’s diagnosis has required expensive imaging or invasive cerebrospinal fluid collection. This new approach allows patients to have their blood drawn at a standard medical office, with labs analyzing the sample for specific biomarkers. If these proteins are detected, the patient may then be referred for confirmatory tests and begin treatment earlier.

Supporting Earlier Treatment and Better Research

Early detection is crucial for effective treatment. Many Alzheimer’s drugs are more beneficial when administered during the disease’s early stages. This blood test can identify potential patients sooner, improving clinical outcomes. It also helps pharmaceutical companies recruit participants for trials and monitor drug efficacy over time.

Barriers to Widespread Use

While promising, the Alzheimer’s blood test still faces some hurdles. It’s currently a laboratory-developed test (LDT) and has not yet received FDA approval. Because of this, it’s often not covered by insurance and remains a costly out-of-pocket option for most people.

A Look Ahead

The potential impact of this innovation is immense. By making early Alzheimer’s detection more accessible, the test could transform clinical care and research. As approval processes advance and accessibility improves, this technology may reshape how we diagnose and treat neurodegenerative conditions.

A healthcare professional in a sterile gown and gloves holds an endoscope, with a red arrow pointing toward the device. Beside it, a handheld cleaning brush is shown, symbolizing the manual cleaning process. Text overlay reads “Not sterile. Just safe?”

Ariana and Mark examine the complexities of endoscope reprocessing, one of the most difficult tasks in medical device hygiene.

Sterilizing medical devices using various FDA-approved methods - Image showing three medical-related items—a pulse oximeter, surgical scissors, and a catheter with a Luer lock—on a light background. A bold label at the top reads ‘How to sterilize?’ with an arrow pointing to the pulse oximeter, indicating a question about sterilization methods for these devices.

Ariana and Mark walk through FDA-approved options and explain how to select the right one for your product. From metals to plastics and electronics, not all devices can handle the same process.

X-ray image showing two human knees side-by-side. The right knee appears intact with natural bone structure, while the left knee has a visible knee replacement implant, including metallic components. A bold caption in the upper center reads "Bone or not?" and a red curved arrow points from the text to the knee with the implant, emphasizing the contrast between natural bone and artificial joint.

In this episode of MedDevice by Design, Ariana and Mark dive into the biomechanics and materials science behind osseointegration for implants.

Split image showing two close-up views of a human eye. On the left, the eye is seen through thick black-framed glasses, indicating impaired vision. On the right, the same eye is enhanced with a futuristic digital overlay of concentric circles and interface elements, suggesting advanced vision restoration technology. A red curved arrow points from left to right, implying improvement. Bold text at the top reads "Restoring Vision?"

Ariana and Mark explore how accommodative intraocular lens technology may one day restore natural vision for people who require cataract surgery or suffer from presbyopia. As Mark shares, traditional bifocals are not ideal, and new lens solutions may offer better outcomes.